ANTM logo

Elevance Health (ANTM) Selling, General & Administrative Expenses

Annual SG&A

$17.69 B
+$1.77 B+11.13%

31 December 2022

3-Year Change

+11.13%
ANTM annual selling, general & administrative expenses is up +11.13% over the past 3 years

All-time High

$17.69 B
ANTM annual selling, general & administrative expenses is currently at an all-time high
Annual Total Expenses$148.83 B
ANTM annual total expenses is $148.83 billion
Annual Operating Expenses$31.49 B
ANTM annual total operating expenses is $31.49 billion
Annual Revenue$156.59 B
ANTM annual revenue is $156.59 billion
Annual Net Income$6.03 B
ANTM annual net profit is $6.03 billion

ANTM Selling, General & Administrative Expenses Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly SG&A

$4.56 B
+$48.00 M+1.06%

31 December 2022

3-Year Change

+8.05%
ANTM quarterly selling, general & administrative expenses is up +8.05% over the past 3 years

All-time High

$10.61 B
ANTM quarterly selling, general & administrative expenses is currently -57.01% below its historical high of $10.61 billion
Quarterly Total Expenses$38.77 B
ANTM quarterly total expenses is $38.77 billion
Quarterly Operating Expenses$8.46 B
ANTM quarterly total operating expenses is $8.46 billion
Quarterly Revenue$39.93 B
ANTM quarterly revenue is $39.93 billion
Quarterly Net Income$949.00 M
ANTM quarterly net profit is $949.00 million

ANTM Quarterly SG&A Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM SG&A

$116.21 B
+$2.64 B+2.32%

31 December 2022

3-Year Change

+630.24%
ANTM TTM selling, general & administrative expenses is up +630.24% over the past 3 years

All-time High

$17.69 B
Annual Total Expenses$148.83 B
ANTM annual total expenses is $148.83 billion
Annual Operating Expenses$31.49 B
ANTM annual total operating expenses is $31.49 billion
TTM Revenue$156.59 B
ANTM TTM revenue is $156.59 billion
TTM Net Income$6.03 B
ANTM TTM net profit is $6.03 billion

ANTM TTM SG&A Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

ANTM Selling, General & Administrative Expenses Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year---
3 y3 years+11.1%+8.1%+630.2%
5 y5 years+32.3%+30.3%+769.6%

ANTM Selling, General & Administrative Expenses High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 years
5 y5 years
alltimeall timeat high-57.0%+557.1%

Elevance Health Selling, General & Administrative Expenses History

DateAnnualQuarterlyTTM
Dec 2022
$17.69 B(+11.1%)
$4.56 B(+1.1%)
$17.69 B(+2.0%)
Sept 2022
-
$4.51 B(+5.7%)
$17.35 B(+3.4%)
June 2022
-
$4.27 B(-1.7%)
$16.78 B(+2.7%)
Mar 2022
-
$4.34 B(+2.8%)
$16.33 B(+2.6%)
Dec 2021
$15.91 B(-8.8%)
$4.22 B(+7.0%)
$15.91 B(-0.6%)
Sept 2021
-
$3.95 B(+3.3%)
$16.01 B(-7.8%)
June 2021
-
$3.82 B(-2.6%)
$17.37 B(-1.3%)
Mar 2021
-
$3.92 B(-9.1%)
$17.59 B(+0.8%)
Dec 2020
$17.45 B(+30.6%)
$4.32 B(-18.6%)
$17.45 B(+4.9%)
Sept 2020
-
$5.30 B(+31.1%)
$16.63 B(+12.8%)
June 2020
-
$4.05 B(+7.0%)
$14.75 B(+5.5%)
Mar 2020
-
$3.78 B(+8.0%)
$13.98 B(+4.6%)
Dec 2019
$13.36 B(-4.7%)
$3.50 B(+2.5%)
$13.36 B(-0.9%)
Sept 2019
-
$3.42 B(+4.3%)
$13.48 B(-0.9%)
June 2019
-
$3.28 B(+3.5%)
$13.61 B(-1.1%)
Mar 2019
-
$3.17 B(-12.5%)
$13.76 B(-1.9%)
Dec 2018
$14.02 B(+10.8%)
$3.62 B(+2.0%)
$14.02 B(+1.6%)
Sept 2018
-
$3.55 B(+3.4%)
$13.80 B(+4.0%)
June 2018
-
$3.43 B(0.0%)
$13.26 B(+2.9%)
Mar 2018
-
$3.43 B(+1.0%)
$12.89 B(+1.9%)
Dec 2017
$12.65 B(+0.7%)
$3.39 B(+12.7%)
$12.65 B(+1.0%)
Sept 2017
-
$3.01 B(-1.4%)
$12.52 B(-0.9%)
June 2017
-
$3.05 B(-4.3%)
$12.63 B(+0.7%)
Mar 2017
-
$3.19 B(-2.3%)
$12.55 B(-0.1%)
Dec 2016
$12.56 B(+0.2%)
$3.27 B(+4.5%)
$12.56 B(-0.0%)
Sept 2016
-
$3.12 B(+5.2%)
$12.56 B(+0.4%)
June 2016
-
$2.97 B(-7.2%)
$12.52 B(-0.6%)
Mar 2016
-
$3.20 B(-2.1%)
$12.59 B(+0.4%)
Dec 2015
$12.53 B(+6.7%)
$3.27 B(+6.1%)
$12.53 B(+1.9%)
Sept 2015
-
$3.08 B(+1.3%)
$12.30 B(+0.9%)
June 2015
-
$3.04 B(-3.3%)
$12.19 B(+1.3%)
Mar 2015
-
$3.15 B(+3.7%)
$12.03 B(+2.4%)
Dec 2014
$11.75 B(+18.0%)
$3.03 B(+2.2%)
$11.75 B(+3.4%)
Sept 2014
-
$2.97 B(+2.9%)
$11.36 B(+3.9%)
June 2014
-
$2.89 B(+0.8%)
$10.94 B(+4.3%)
Mar 2014
-
$2.86 B(+8.2%)
$10.49 B(+5.3%)
Dec 2013
$9.95 B(+14.7%)
$2.65 B(+4.0%)
$9.95 B(+3.0%)
Sept 2013
-
$2.54 B(+4.4%)
$9.66 B(+5.0%)
June 2013
-
$2.44 B(+4.6%)
$9.20 B(+4.0%)
Mar 2013
-
$2.33 B(-1.1%)
$8.84 B(+1.9%)
Dec 2012
$8.68 B
$2.35 B(+13.3%)
$8.68 B(+1.5%)
Sept 2012
-
$2.08 B(-0.2%)
$8.55 B(-0.5%)
DateAnnualQuarterlyTTM
June 2012
-
$2.08 B(-3.9%)
$8.60 B(+0.8%)
Mar 2012
-
$2.17 B(-2.8%)
$8.52 B(+1.1%)
Dec 2011
$8.44 B(-3.4%)
$2.23 B(+5.1%)
$8.44 B(-1.3%)
Sept 2011
-
$2.12 B(+5.4%)
$8.55 B(+0.7%)
June 2011
-
$2.01 B(-3.1%)
$8.49 B(-1.7%)
Mar 2011
-
$2.08 B(-11.3%)
$8.63 B(-1.1%)
Dec 2010
$8.73 B(-4.1%)
$2.34 B(+13.4%)
$8.73 B(-0.8%)
Sept 2010
-
$2.06 B(-4.2%)
$8.81 B(-2.2%)
June 2010
-
$2.15 B(-0.9%)
$9.00 B(-0.6%)
Mar 2010
-
$2.17 B(-10.0%)
$9.06 B(-0.6%)
Dec 2009
$9.11 B(+7.2%)
$2.42 B(+6.9%)
$9.11 B(+7.1%)
Sept 2009
-
$2.26 B(+2.5%)
$8.50 B(+0.5%)
June 2009
-
$2.21 B(-1.0%)
$8.46 B(-0.1%)
Mar 2009
-
$2.23 B(+23.2%)
$8.48 B(-0.2%)
Dec 2008
$8.50 B(-2.3%)
$1.81 B(-18.5%)
$8.50 B(-3.5%)
Sept 2008
-
$2.22 B(+0.1%)
$8.81 B(+0.3%)
June 2008
-
$2.22 B(-1.3%)
$8.78 B(-0.5%)
Mar 2008
-
$2.25 B(+6.1%)
$8.82 B(+1.3%)
Dec 2007
$8.70 B(-1.3%)
$2.12 B(-3.2%)
$8.70 B(-1.5%)
Sept 2007
-
$2.19 B(-3.1%)
$8.84 B(-0.1%)
June 2007
-
$2.26 B(+6.0%)
$8.84 B(+0.8%)
Mar 2007
-
$2.13 B(-5.4%)
$8.78 B(-0.5%)
Dec 2006
$8.82 B(+21.2%)
$2.25 B(+2.5%)
$8.82 B(+4.6%)
Sept 2006
-
$2.20 B(+0.3%)
$8.43 B(+4.3%)
June 2006
-
$2.19 B(+0.9%)
$8.08 B(+4.7%)
Mar 2006
-
$2.17 B(+16.6%)
$7.72 B(+6.1%)
Dec 2005
$7.27 B(+109.1%)
$1.86 B(+0.8%)
$7.27 B(+11.0%)
Sept 2005
-
$1.85 B(+0.8%)
$6.55 B(+19.4%)
June 2005
-
$1.83 B(+6.0%)
$5.49 B(+23.5%)
Mar 2005
-
$1.73 B(+51.6%)
$4.44 B(+27.7%)
Dec 2004
$3.48 B(-71.8%)
$1.14 B(+45.7%)
$3.48 B(+48.8%)
Sept 2004
-
$782.60 M(-0.9%)
$2.34 B(-0.0%)
June 2004
-
$789.70 M(+3.2%)
$2.34 B(+0.7%)
Mar 2004
-
$765.00 M(-2.4%)
$2.32 B(-82.0%)
Sept 2003
-
$783.50 M(+1.2%)
$12.89 B(+0.8%)
June 2003
-
$773.90 M(+8.0%)
$12.79 B(+1.8%)
Mar 2003
-
$716.40 M(-93.2%)
$12.56 B(+6.1%)
Dec 2002
$12.35 B(+521.6%)
$10.61 B(+1452.2%)
$11.84 B(+577.3%)
Sept 2002
-
$683.70 M(+25.6%)
$1.75 B(+13.6%)
June 2002
-
$544.40 M(+4.7%)
$1.54 B(+54.7%)
Dec 2001
$1.99 B
$520.20 M(+9.7%)
$994.50 M(+109.7%)
Sept 2001
-
$474.30 M
$474.30 M

FAQ

  • What is Elevance Health annual selling, general & administrative expenses?
  • What is the all time high annual SG&A for Elevance Health?
  • What is Elevance Health quarterly selling, general & administrative expenses?
  • What is the all time high quarterly SG&A for Elevance Health?
  • What is Elevance Health TTM selling, general & administrative expenses?
  • What is the all time high TTM SG&A for Elevance Health?

What is Elevance Health annual selling, general & administrative expenses?

The current annual SG&A of ANTM is $17.69 B

What is the all time high annual SG&A for Elevance Health?

Elevance Health all-time high annual selling, general & administrative expenses is $17.69 B

What is Elevance Health quarterly selling, general & administrative expenses?

The current quarterly SG&A of ANTM is $4.56 B

What is the all time high quarterly SG&A for Elevance Health?

Elevance Health all-time high quarterly selling, general & administrative expenses is $10.61 B

What is Elevance Health TTM selling, general & administrative expenses?

The current TTM SG&A of ANTM is $116.21 B

What is the all time high TTM SG&A for Elevance Health?

Elevance Health all-time high TTM selling, general & administrative expenses is $17.69 B